How often it happens The rates vary by trial and population: 2,3 TRIUMPH-4 (obesity with knee osteoarthritis): 8.8% on 9 mg, 20.9% on 12 mg, 0.7% on placebo TRANSCEND-T2D-1 (type 2 diabetes): 4.5% on 4 mg, 2.3% on 9 mg, 4.4% on 12 mg, 0% on placebo Phase 2 trial (Jastreboff 2023): not reported The TRIUMPH-4 numbers are markedly higher than those of TRANSCEND-T2D-1
Step four: starting retatrutide After the full washout period, you begin retatrutide
This hormone tells your brain youre full, slows down how quickly food leaves your stomach, and helps regulate blood sugar levels
Higher doses of any GLP-1 medication, which produce faster weight loss, may increase telogen effluvium likelihood
Feel your best while on your GLP-1 medications with our delicious drink mix